HRT may also be considered in women with established ischemic heart disease (IHD) for menopausal symptom relief, following careful counseling and shared decision making
Transdermal low-dose oestrogen combined, if indicated, with micronised progesterone or dydrogesterone is preferred
Transdermal low-dose oestrogen combined, if indicated, with micronised progesterone or dydrogesterone is preferred
September 23, 2026 at 8:55 PM
HRT may also be considered in women with established ischemic heart disease (IHD) for menopausal symptom relief, following careful counseling and shared decision making
Transdermal low-dose oestrogen combined, if indicated, with micronised progesterone or dydrogesterone is preferred
Transdermal low-dose oestrogen combined, if indicated, with micronised progesterone or dydrogesterone is preferred
HRT type, dose and route of administration should be based on individual health status, cardiovascular and thromboembolic risk factors
In women at high risk, transdermal oestrogen combined with micronised progesterone or dydrogesterone, if the uterus is intact, is the preferred option
In women at high risk, transdermal oestrogen combined with micronised progesterone or dydrogesterone, if the uterus is intact, is the preferred option
September 23, 2026 at 8:54 PM
HRT type, dose and route of administration should be based on individual health status, cardiovascular and thromboembolic risk factors
In women at high risk, transdermal oestrogen combined with micronised progesterone or dydrogesterone, if the uterus is intact, is the preferred option
In women at high risk, transdermal oestrogen combined with micronised progesterone or dydrogesterone, if the uterus is intact, is the preferred option
Dydrogesterone Drug Market Competitive Landscape Report 2035 | WiseGuyReports www.wiseguyreports.com/reports/dydr...
Dydrogesterone Drug Market Competitive Landscape Report 2035
The Dydrogesterone Drug Market is expected to grow from 846.3 USD Million in 2025 to 1,500 USD Million by 2035. The Dydrogesterone Drug Market CAGR (growth rate) is expected to be around 5.9% | Wisegu...
www.wiseguyreports.com
August 12, 2026 at 6:26 AM
Dydrogesterone Drug Market Competitive Landscape Report 2035 | WiseGuyReports www.wiseguyreports.com/reports/dydr...
[2/3] dydrogesterone tablets have been newly added to the "National Essential Drugs List (2026 Edition)", which will be effective from September 1, 2026. Dydrogesterone tablets can be used to treat diseases caused by insufficient endogenous progesterone. This addition to the Essential
July 15, 2026 at 9:24 AM
[2/3] dydrogesterone tablets have been newly added to the "National Essential Drugs List (2026 Edition)", which will be effective from September 1, 2026. Dydrogesterone tablets can be used to treat diseases caused by insufficient endogenous progesterone. This addition to the Essential
[1/3] 2026-07-15 17:11:39 - [Aurite: The main drug dydrogesterone tablets have been added to the 2026 version of the National Essential Drugs List] Orient announced that the National Health Commission and three other departments issued notices that the company's main drug
July 15, 2026 at 9:24 AM
[1/3] 2026-07-15 17:11:39 - [Aurite: The main drug dydrogesterone tablets have been added to the 2026 version of the National Essential Drugs List] Orient announced that the National Health Commission and three other departments issued notices that the company's main drug
[2/3] dydrogesterone tablets have been newly added to the "National Essential Drugs List (2026 Edition)", which will be effective from September 1, 2026. Dydrogesterone tablets can be used to treat diseases caused by insufficient endogenous progesterone. This addition to the Essential
July 15, 2026 at 9:20 AM
[2/3] dydrogesterone tablets have been newly added to the "National Essential Drugs List (2026 Edition)", which will be effective from September 1, 2026. Dydrogesterone tablets can be used to treat diseases caused by insufficient endogenous progesterone. This addition to the Essential
[1/3] 2026-07-15 17:11:39 - [Aurite: The main drug dydrogesterone tablets have been added to the 2026 version of the National Essential Drugs List] Orient announced that the National Health Commission and three other departments issued notices that the company's main drug
July 15, 2026 at 9:20 AM
[1/3] 2026-07-15 17:11:39 - [Aurite: The main drug dydrogesterone tablets have been added to the 2026 version of the National Essential Drugs List] Orient announced that the National Health Commission and three other departments issued notices that the company's main drug
#womenshealth #GedeonRichter #Nalvee #dydrogesterone #brandedgeneric #UK #HRT #hormonereplacementtherapy #HRToptions #menopause #Dydrogesteroneonlytablet #personalisedcare #Clinicaltrials #postmenopausalwomen #personalisedHRT #menopausetreatment #HRTportfolio
pharmatimes.com/news/gedeon-...
pharmatimes.com/news/gedeon-...
Gedeon Richter launches Nalvee in UK to expand HRT options for menopause - PharmaTimes
Dydrogesterone-only tablet returns after 17-year absence to support personalised care
pharmatimes.com
August 5, 2025 at 9:55 AM
[CW: Misgendering, bigotry, medical]
Where to even begin:
I've had a WILD fucking past 5 days. I'm all set to do HRT on September 12th, but I foolishly talk about fatigue and the endo delays HRT. AND then I get unplanned labs the next day. Also dydrogesterone isn't in the USA so neighbors of […]
Where to even begin:
I've had a WILD fucking past 5 days. I'm all set to do HRT on September 12th, but I foolishly talk about fatigue and the endo delays HRT. AND then I get unplanned labs the next day. Also dydrogesterone isn't in the USA so neighbors of […]
Original post on blahaj.zone
blahaj.zone
September 17, 2024 at 8:24 PM
[CW: Misgendering, bigotry, medical]
Where to even begin:
I've had a WILD fucking past 5 days. I'm all set to do HRT on September 12th, but I foolishly talk about fatigue and the endo delays HRT. AND then I get unplanned labs the next day. Also dydrogesterone isn't in the USA so neighbors of […]
Where to even begin:
I've had a WILD fucking past 5 days. I'm all set to do HRT on September 12th, but I foolishly talk about fatigue and the endo delays HRT. AND then I get unplanned labs the next day. Also dydrogesterone isn't in the USA so neighbors of […]
Researchers developed a new treatment using a nanocomposite made of polydopamine and dydrogesterone. It targets endometriosis while protecting ovaries and fertility.
July 20, 2025 at 6:00 AM
Researchers developed a new treatment using a nanocomposite made of polydopamine and dydrogesterone. It targets endometriosis while protecting ovaries and fertility.
#GedeonRichter has launched a dydrogesterone-only hormone replacement therapy (#HRT) formulation in the #UK, Nalvee, as an option for non-hysterectomised #women receiving oestrogen therapy.
pharmaphorum.com/news/gedeon-...
pharmaphorum.com/news/gedeon-...
Gedeon Richter brings HRT option back to the UK market
After a 17-year absence, a dydrogesterone-only hormone replacement therapy (HRT) formulation is available again in the UK market.
pharmaphorum.com
August 5, 2025 at 10:43 AM
#GedeonRichter has launched a dydrogesterone-only hormone replacement therapy (#HRT) formulation in the #UK, Nalvee, as an option for non-hysterectomised #women receiving oestrogen therapy.
pharmaphorum.com/news/gedeon-...
pharmaphorum.com/news/gedeon-...
BPOM Issues First Generic Drug Permit for Infertility Treatment in Indonesia - https://en.tempo.co/read/2068707/bpom-issues-first-generic-drug-permit-for-infertility-treatment-in-indonesia
BPOM Issues First Generic Drug Permit for Infertility Treatment in Indonesia
The Food and Drug Monitoring Agency (BPOM) has issued the first generic drug permit in Indonesia containing dydrogesterone. This drug is given to couples with fertility problems.
en.tempo.co
November 26, 2025 at 2:24 AM
BPOM Issues First Generic Drug Permit for Infertility Treatment in Indonesia - https://en.tempo.co/read/2068707/bpom-issues-first-generic-drug-permit-for-infertility-treatment-in-indonesia
BPOM Terbitkan Obat Generik Pertama Dydrogesterone untuk Terapi Infertilitas - https://gaya.tempo.co/read/2068652/bpom-terbitkan-obat-generik-pertama-dydrogesterone-untuk-terapi-infertilitas
BPOM Terbitkan Obat Generik Pertama Dydrogesterone untuk Terapi Infertilitas
BPOM menerbitkan izin edar obat generik pertama dengan kandungan dydrogesterone. Obat ini diberikan untuk pasangan dengan gangguan kesuburan.
gaya.tempo.co
November 25, 2025 at 4:24 PM
BPOM Terbitkan Obat Generik Pertama Dydrogesterone untuk Terapi Infertilitas - https://gaya.tempo.co/read/2068652/bpom-terbitkan-obat-generik-pertama-dydrogesterone-untuk-terapi-infertilitas
Feed: "Medical News, Health News Latest, Medical News Today - Medical Dialogues |"
By: Medha Baranwal on Wednesday, April 8, 2026
By: Medha Baranwal on Wednesday, April 8, 2026
Oral Dydrogesterone Shows No Significant Benefit in Preventing Preterm Birth: Meta-Analysis
Egypt: A recent
medicaldialogues.in
April 8, 2026 at 6:03 PM
Feed: "Medical News, Health News Latest, Medical News Today - Medical Dialogues |"
By: Medha Baranwal on Wednesday, April 8, 2026
By: Medha Baranwal on Wednesday, April 8, 2026
Feed: "PharmaTimes"
By: John Pinching on Tuesday, August 5, 2025
By: John Pinching on Tuesday, August 5, 2025
Gedeon Richter launches Nalvee in UK to expand HRT options for menopause
Dydrogesterone-only tablet returns after 17-year absence to support personalised care
pharmatimes.com
August 6, 2025 at 2:56 AM
Feed: "PharmaTimes"
By: John Pinching on Tuesday, August 5, 2025
By: John Pinching on Tuesday, August 5, 2025